Bluejay Diagnostics (BJDX) Long-Term Deferred Tax (2022)
Bluejay Diagnostics (BJDX) has disclosed Long-Term Deferred Tax for 1 consecutive years, with $2.7 million as the latest value for Q4 2022.
- Quarterly Long-Term Deferred Tax changed N/A to $2.7 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2022, changed N/A year-over-year, with the annual reading at $2.7 million for FY2022, N/A changed from the prior year.
- Long-Term Deferred Tax hit $2.7 million in Q4 2022 for Bluejay Diagnostics.
- In the past five years, Long-Term Deferred Tax ranged from a high of $2.7 million in Q4 2022 to a low of $2.7 million in Q4 2022.